Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer
Nils D. Arvold(Dana-Farber Cancer Institute), Theodore S. Hong(Massachusetts General Hospital), David P. Ryan(East Carolina University), Raymond Wadlow(Broad Institute), Jennifer Y. Wo(Massachusetts General Hospital), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Eunice L. Kwak(Harvard University), Carlos Fernández‐del Castillo(Massachusetts General Hospital), Jill N. Allen(Harvard University), Andrzej Niemierko(Harvard University)
Cited by 70
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k